scispace - formally typeset
M

Martijn A. Langereis

Researcher at Utrecht University

Publications -  37
Citations -  2450

Martijn A. Langereis is an academic researcher from Utrecht University. The author has contributed to research in topics: Interferon & Stress granule. The author has an hindex of 26, co-authored 37 publications receiving 1951 citations. Previous affiliations of Martijn A. Langereis include Texas A&M Health Science Center & Texas A&M University System.

Papers
More filters
Journal ArticleDOI

Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution.

TL;DR: The crystal structure of a coronavirus (CoV) HE in complex with its receptor is reported and the plasticity of the CoV HE receptor-binding site is attributed to evolutionary flexibility conferred by functional redundancy between HE and its companion spike protein S.
Journal ArticleDOI

MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells

TL;DR: This study dissected the IFN-α/β-stimulatory activity of different viral RNA species produced during picornavirus infection, both by RNA transfection and in infected cells in which specific steps of viral RNA replication were inhibited.
Journal ArticleDOI

Enterovirus 2Apro Targets MDA5 and MAVS in Infected Cells

TL;DR: A critical role of 2Apro is identified by cleaving MDA5 and MAVS and shows that enteroviruses use a common strategy to counteract the interferon response in infected cells.
Journal ArticleDOI

Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses.

TL;DR: It is shown that cellular infection with MERS-CoV does not lead to the formation of SGs and that p4a suppressing the PKR-dependent stress response pathway, probably by sequestering dsRNA.
Journal ArticleDOI

Small molecule ISRIB suppresses the integrated stress response within a defined window of activation.

TL;DR: It is demonstrated here that ISRIB inhibits low-level ISR activity, but does not affect strong ISR signaling, and the effects of pharmacological activation of eIF2B are tuned by P-eIF2α concentration, which provides a plausible mechanism of howISRIB counteracts toxic chronic ISRactivity, without disturbing the cytoprotective effects of a strong acute ISR.